Giuseppe Viale

Active 1987–2025

336
Papers
95,406
Citations
154
h-index
329
i10-index

Citations

Citations per year for Giuseppe Viale1980: 1 citations1981: 2 citations1987: 1 citations1988: 2 citations1989: 3 citations1990: 5 citations1991: 4 citations1992: 2 citations1993: 2 citations1994: 10 citations1995: 20 citations1996: 27 citations1997: 30 citations1998: 45 citations1999: 57 citations2000: 98 citations2001: 116 citations2002: 116 citations2003: 166 citations2004: 139 citations2005: 163 citations2006: 202 citations2007: 217 citations2008: 291 citations2009: 340 citations2010: 456 citations2011: 486 citations2012: 478 citations2013: 573 citations2014: 620 citations2015: 728 citations2016: 793 citations2017: 891 citations2018: 766 citations2019: 2,829 citations2020: 3,257 citations2021: 3,235 citations2022: 2,797 citations2023: 2,315 citations2024: 3,583 citations2025: 1,725 citations2026: 78 citations1982–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,841 citing papers, 21.2% of this breakdownChina: 3,648 citing papers, 11.3% of this breakdownItaly: 2,443 citing papers, 7.6% of this breakdownUnited Kingdom: 1,869 citing papers, 5.8% of this breakdownGermany: 1,536 citing papers, 4.8% of this breakdownFrance: 1,204 citing papers, 3.7% of this breakdownCanada: 1,065 citing papers, 3.3% of this breakdownSpain: 1,003 citing papers, 3.1% of this breakdownNetherlands: 931 citing papers, 2.9% of this breakdownSwitzerland: 915 citing papers, 2.8% of this breakdownJapan: 904 citing papers, 2.8% of this breakdownAustralia: 837 citing papers, 2.6% of this breakdown
0%21.2%Other 28.1%

Fields

  • Medicine48.7%
  • Biochemistry, Genetics and Molecular Biology40.6%
  • Immunology and Microbiology3.7%
  • Computer Science2.8%
  • Engineering0.9%
  • Agricultural and Biological Sciences0.6%
  • Other2.7%

Topics

  • Breast Cancer Treatment Studies9.4%
  • HER2/EGFR in Cancer Research4.6%
  • Cancer Immunotherapy and Biomarkers4.5%
  • Breast Lesions and Carcinomas3.8%
  • Cancer Cells and Metastasis3%
  • Advanced Breast Cancer Therapies2.6%
  • Other72.1%

Coauthors

All papers

Open in search
  1. Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph P. Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R. Lakhani, Greg Yothers, Christine Campbell, Charles E. Geyer - New England Journal of Medicine 2021 cited by 1,665

  2. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karen Willard‐Gallo, Sherene Loi - Annals of Oncology 2014 cited by 3,136

  3. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 1,497

  4. Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giuseppe Penna, María Rescigno - Cancer Cell 2021 cited by 495

  5. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moïse Namer, C. Kent Osborne, Ann H. Partridge, Frédérique Penault‐Llorca, Charles M. Perou, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P. Winer, William C. Wood - Annals of Oncology 2013 cited by 3,715

  6. HER2-Low Breast Cancer: Pathological and Clinical Landscape

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 802

  7. Spatial predictors of immunotherapy response in triple-negative breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2023 cited by 325

  8. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

    Authors: , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2018 cited by 2,454

  9. A gut-vascular barrier controls the systemic dissemination of bacteria

    Authors: , , , , , , , , , , , , - Science 2015 cited by 701

  10. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Viviana Galimberti, Hebatallah Gamal El Din Mohamed Mahmoud, Judy E. Garber, Michael Gnant, William J. Gradishar, Bahadır M. Güllüoğlu, Nadia Harbeck, Chiun‐Sheng Huang, Jens Huober, André Ilbawi, Zefei Jiang, Steven Johnston, Eun Sook Lee, Sibylle Loibl, Monica Morrow, Ann H. Partridge, Martine Piccart, Philip Poortmans, Aleix Prat, Meredith M. Regan, Isabella Rubio, Hope S. Rugo, Emiel J. Rutgers, Felix Sedlmayer, Vladimir Semiglazov, Hans-Joerg Senn, Zhiming Shao, Tanja Španić, Petra Tesařová, Beat Thürlimann, Sergei Tjulandin, Masakazu Toi, Maureen Trudeau, Nicholas Turner, Inez Vaz Luis, Giuseppe Viale, Toru Watanabe, William P. Weber, Eric P. Winer, Binghe Xu - Annals of Oncology 2021 cited by 803

  11. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , René Bernards, Konstantinos Tryfonidis, Emiel J. Rutgers, Martine Piccart - New England Journal of Medicine 2016 cited by 2,051

  12. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James L. Wittliff, Antonio C. Wolff - Archives of Pathology & Laboratory Medicine 2010 cited by 4,267

  13. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sunil R. Lakhani, W Janni, Barbro Linderholm, T.-W. Liu, Niklas Loman, Larissa A. Korde, Sibylle Loibl, Peter C. Lucas, Frederik Marmé, E. Martinez de Dueñas, Robin McConnell, Kelly‐Anne Phillips, Martine Piccart, Giovanna Rossi, Rita K. Schmutzler, Elżbieta Senkus, Zhi-Ming Shao, Priyanka Sharma, Christian F. Singer, Tanja Španić, Elmar Stickeler, Masakazu Toi, Tiffany A. Traina, Giuseppe Viale, Gabriele Zoppoli, Y.H. Park, Rinat Yerushalmi, Huan Yang, D. Pang, Kyung Hae Jung, Audrey Mailliez, Zhaoqing Fan, Isabelle Tennevet, J. Zhang, T. Nagy, Gabe S. Sonke, Qiuhong Sun, Marina Parton, Marco Colleoni, Marcus Schmidt, Adam Brufsky, W. Razaq, Bella Kaufman, David Cameron, Christine Campbell, Andrew Tutt, P. Sevelda, Ferdinand Haslbauer, Monika Penzinger, Leopold Öhler, Christoph Tinchon, Richard Greil, Sonja Heibl, Rupert Bartsch, Viktor Wette, Christian F. Singer, Claudia Pasterk, Ruth Helfgott, Gunda Pristauz-Telsnigg, Herbert Stöger, A. Weltermann, Daniel Egle, I. Thiel, David Fuchs, Holger Rumpold, Kathrin Strasser‐Weippl, Beate Rautenberg, Volkmar Müller, Marcus Schmidt, Stefan Paepke and 509 more - Annals of Oncology 2022 cited by 447

  14. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mitch Dowsett, Frances Duane, Vaughan Evans, Marianne Ewertz, Bernard Fisher, John Forbes, Leslie G. Ford, J.-C. Gazet, Richard D. Gelber, Lucy Gettins, Luca Gianni, Michael Gnant, Jon Godwin, Aron Goldhirsch, Pamela J. Goodwin, Richard Gray, Daniel F. Hayes, Catherine Hill, James N. Ingle, Reshma Jagsi, R. Jakesz, Sam James, Wolfgang Janni, Hui Liu, Zulian Liu, Caroline Lohrisch, Sibylle Loibl, Liz MacKinnon, Andreas Makris, Eleftherios P. Mamounas, Gurdeep Mannu, Miguel Martín, S. Mathoulin, L. Mauriac, Paul McGale, Theresa McHugh, Philip Morris, Hirofumi Mukai, Larry Norton, Yasuo Ohashi, Ivo A. Olivotto, Soon Young Paik, Hongchao Pan, Richárd Pető, Martine Piccart, Lori J. Pierce, Philip Poortmans, Trevor J. Powles, K.I. Pritchard, Joseph Ragaz, Vinod Raina, Peter M. Ravdin, Simon Read, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Suzy Scholl, Dennis J. Slamon, Lidija Sölkner, Joseph A. Sparano, Seth M. Steinberg, Rosemary Sutcliffe, Sandra M. Swain, Carolyn Taylor, Andrew Tutt, Pinuccia Valagussa, Cornelis J.�H. van de Velde, Jos A. van der Hage, Giuseppe Viale, Gϋnter von Minckwitz and 10 more - The Lancet Oncology 2017 cited by 1,133

  15. Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

    Authors: , , , , , , , - The Lancet Oncology 2018 cited by 993

  16. Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 1,399

  17. Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , SOUND Trial Group, Fabio Bassi, Fulvio Borella, Pietro Caldarella, Marco Colleoni, Giovanni Corso, Silvia Dellapasqua, Alberta Ferrari, Carlos A. Garcia‐Etienne, Damiano Gentile, Alessandro Germano, L.P. Grosso, Mattia Intra, Monica Iorfida, José Vila, Gennaro Limite, Germana Lissidini, G Macellari, Francesca Magnoni, Ilaria Maugeri, Manuelita Mazza, Emilia Montagna, Paola Naninato, Luca Nicosia, Roberto Orecchia, Alberto F. Pierini, Claudia Rauh, Massimo Rinaldo, Anna Rotili, Nicole Rotmensz, Anna Rita Vento, Veronica Zuber - JAMA Oncology 2023 cited by 498

  18. Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2022 cited by 386

  19. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 799

  20. Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2013 cited by 1,647

  21. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Gϋnter von Minckwitz, Toru Watanabe, Timothy J. Whelan, Eric P. Winer, Binghe Xu - Annals of Oncology 2015 cited by 1,837

  22. Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2021 cited by 240

  23. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simon Read, Ewan Straiton, Raimund Jakesz, Christian Fesl, Olivia Pagani, Richard Gelber, Michelino De Laurentiis, Sabino De Placido, Ciro Gallo, Kathy Albain, Stewart Anderson, Rodrigo Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith Bliss, Etienne Brain, Lisa Carey, Robert Coleman, Jack Cuzick, Nancy Davidson, Lucia Del Mastro, Angelo Di Leo, James Dignam, Mitch Dowsett, Bent Ejlertsen, Matthew Goetz, Pam Goodwin, Pat Halpin-Murphy, Dan Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori Pierce, Philip Poortmans, Kathleen I Pritchard, Vinod Raina, Daniel Rea, John Robertson, Emiel Rutgers, Tanja Spanic, Joseph Sparano, Guenther Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Tim Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Sandra M Swain - The Lancet Oncology 2022 cited by 299

  24. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isabel Frahm, Joselyn Sanchez, Miluska Castillo, Najat Bouchmaa, Reena R. Md Zin, Ruohong Shui, Timothy Onyuma, Wentao Yang, Zaheed Husain, Karen Willard‐Gallo, An Coosemans, Edith Perez, Elena Provenzano, Paula Gonzalez Ericsson, Eduardo Richardet, Ravi Mehrotra, Sandra Sarancone, Anna Ehinger, David L. Rimm, John M.S. Bartlett, Giuseppe Viale, Carsten Denkert, Akira I. Hida, Christos Sotiriou, Sibylle Loibl, Stephen M. Hewitt, Sunil Badve, W. Fraser Symmans, Rim S. Kim, Giancarlo Pruneri, Shom Goel, Prudence A. Francis, Gloria Inurrigarro, Rin Yamaguchi, Hernán Garcı́a Rivello, Hugo M. Horlings, Saïd Afqir, Roberto Salgado, Sylvia Adams, Marleen Kok, Maria Vittoria Dieci, Stefan Michiels, Sandra Demaria, Sherene Loi, The International Immuno-Oncology Biomarker Working Group, Khalid El Bairi, Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh-Ardalan, Luciana Botinelly Mendonça Fujimoto, Luz F. Sua, Shiwei Liu, Huang‐Chun Lien, Pawan Kirtani, Marcelo Balancin, Hicham El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I‐Chun Chen, Veronica Bautista and 454 more - npj Breast Cancer 2021 cited by 275